Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

TAAT Global Alternatives Inc C.TAAT

Alternate Symbol(s):  TOBAF

TAAT Global Alternatives Inc. is a vertically integrated consumer product and distribution company. The Company develops, manufactures, and distributes alternative product categories, such as tobacco and reduced-risk alternatives, hemp, kratom, and other emerging consumer packaged goods (CPG) segments. The Company operates through two segments: the sale of non-tobacco and tobacco products. The Company is developing nicotine-free and tobacco-free alternatives to traditional cigarettes. The Company utilizes a proprietary, patent-pending process (including a patent-pending refinement technique) with a blend of all-natural ingredients to provide smokers aged above 21 with an alternative to traditional cigarettes that do not contain nicotine or tobacco. The Company has facilities to include a processing plant in Nevada as well as a distribution center in Canton, Ohio, leveraging existing retail shelf space and pipelines into national wholesale channels.


CSE:TAAT - Post by User

Post by fadodix9on Dec 11, 2020 1:43pm
114 Views
Post# 32089487

Future Bioelectronic Medicine

Future Bioelectronic Medicine

Why not lets start discussing the potential advantages of this great news I have here and might read this to take advantage of this great news

Seems a system designed to improve signal fidelity and uncover the full range of electrocardiogram (ECG) and intracardiac signals, elevating the standard of care in electrophysiology through enhanced signal acquisition, digital signal processing, and analysis.
 
Recently, PURE EP could be highlighted in several patient cases conducted live by Andrea Natale, executive medical director of TCAI, and EPLive course director, and Joseph Gallinghouse, MD, as part of a two-day educational meeting for practicing clinical cardiac electrophysiologists.Check Disclaimer on my Profile
<< Previous
Bullboard Posts
Next >>